Nobuki Furubayashi

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 5

Top Topics

Community Dwelling

Ejection Fraction

Tyrosine Kinase

Advanced Non Small Cell Lung Cancer

Top Venues

OncoTargets and therapy

Cancer management and research

Research and reports in urology

This page only lists publications with an associated author ORCID identifier.

Publications

Nobuki Furubayashi, Akinori Minato, Takahito Negishi, Naotaka Sakamoto, Yoohyun Song, Yoshifumi Hori, Toshihisa Tomoda, Mirii Harada, Shingo Tamura, Akihiro Miura, Hiroki Komori, Kentaro Kuroiwa, Narihito Seki, Naohiro Fujimoto, Motonobu Nakamura
Association Between Immune-Related Adverse Events and Efficacy and Changes in the Relative Eosinophil Count Among Patients with Advanced Urothelial Carcinoma Treated by Pembrolizumab. Cancer management and research 14 (2022)
Nobuki Furubayashi, Akinori Minato, Takahito Negishi, Naotaka Sakamoto, Yoohyun Song, Yoshifumi Hori, Toshihisa Tomoda, Mirii Harada, Shingo Tamura, Hiroki Kobayashi, Yamato Wada, Kentaro Kuroiwa, Narihito Seki, Naohiro Fujimoto, Motonobu Nakamura
The Eosinophil Changes, Efficacy and Safety of Pembrolizumab in Advanced Urothelial Carcinoma Patients with an Older Age and a Poor Performance Status. OncoTargets and therapy 15 (2022)
Nobuki Furubayashi, Akinori Minato, Takahito Negishi, Naotaka Sakamoto, Yoohyun Song, Yoshifumi Hori, Toshihisa Tomoda, Shingo Tamura, Kentaro Kuroiwa, Narihito Seki, Naohiro Fujimoto, Motonobu Nakamura
The Association of Clinical Outcomes with Posttreatment Changes in the Relative Eosinophil Counts and Neutrophil-to-Eosinophil Ratio in Patients with Advanced Urothelial Carcinoma Treated with Pembrolizumab. Cancer management and research 13 (2021)
Nobuki Furubayashi, Takahito Negishi, Naotaka Sakamoto, Hozumi Shimokawa, Futoshi Morokuma, Yoohyun Song, Yoshifumi Hori, Toshihisa Tomoda, Noriaki Tokuda, Narihito Seki, Kentaro Kuroiwa, Motonobu Nakamura
Organ-Specific Tumor Response to Pembrolizumab in Advanced Urothelial Carcinoma After Platinum-Based Chemotherapy. OncoTargets and therapy 14 (2021)
Nobuki Furubayashi, Takahito Negishi, Akihiro Miura, Nobutaka Nakamura, Motonobu Nakamura
Organ-Specific Therapeutic Effect of Paclitaxel and Carboplatin Chemotherapy After Platinum-Based Chemotherapy and Pembrolizumab for Metastatic Urothelial Carcinoma. Research and reports in urology 12 (2020)